A carregar...
RANKL Inhibition Through Osteoprotegerin Blocks Bone Loss in Experimental Periodontitis
BACKGROUND: Prevention of alveolar bone destruction is a clinical challenge in periodontal disease treatment. The receptor activator of nuclear factor-kappa B ligand (RANKL) inhibitor osteoprotegerin (OPG) inhibits osteoclastogenesis and suppresses bone resorption. METHODS: To study the effects of R...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2583091/ https://ncbi.nlm.nih.gov/pubmed/17608585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1902/jop.2007.070073 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|